Literature DB >> 21864951

Derivatives of pyrrolo[3,4-d]pyridazinone, a new class of analgesic agents.

Wiesław Malinka1, Aleksandra Redzicka, Magdalena Jastrzębska-Więsek, Barbara Filipek, Małgorzata Dybała, Zbigniew Karczmarzyk, Zofia Urbańczyk-Lipkowska, Przemysław Kalicki.   

Abstract

A series of N2-{2-[4-aryl(benzyl)-1-piperazinyl(piperidinyl)]ethyl}pyrrolo[3,4-d]pyridazinones 4 and related derivatives 5 were synthesized as potential analgesic agents. The structures of the new compounds were elucidated by micro, spectral and X-ray analysis. Analgesic activity of the compounds was investigated in the phenylbenzoquinone induced 'writhing' and 'hot plate' test in mice and at radioligand binding assay. At 'writhing' test all compounds, without exception, were more active than acetylsalicylic acid (ASA) with ED(50) values ranging from 0.04 to 11 mg/kg (i.p.) (ED(50) for ASA--39.15 mg/kg). Analgesic effect at the 'hot plate' test was observed for three compounds 4c,e,f at the dose 3-5 times higher then that of morphine (ED(50)-3.39 mg/kg). At radioligand binding assay of 4c,e,f only compound 4f exhibited affinity for the μ-opioid receptors similar to that of Tramadol. The acute toxicity of the pyrrolopyridazinones 4, 5 were also studied and non toxic effect was observed at the 2000 mg/kg (5a 1420 mg/kg) i.p. dose level. On the basis of the available pharmacological data S-A relationship is discussed. The preferred conformational characteristic of 4, taken 4c as an example, was also described.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864951     DOI: 10.1016/j.ejmech.2011.08.006

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Novel 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]Pyridazinone Exert Anti-Inflammatory Activity without Acute Gastrotoxicity in the Carrageenan-Induced Rat Paw Edema Test.

Authors:  Marta Szandruk-Bender; Anna Merwid-Ląd; Benita Wiatrak; Maciej Danielewski; Stanisław Dzimira; Danuta Szkudlarek; Łukasz Szczukowski; Piotr Świątek; Adam Szeląg
Journal:  J Inflamm Res       Date:  2021-11-02

2.  Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation.

Authors:  Karolina Wakulik; Benita Wiatrak; Łukasz Szczukowski; Dorota Bodetko; Marta Szandruk-Bender; Agnieszka Dobosz; Piotr Świątek; Kazimierz Gąsiorowski
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

3.  Novel 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Exert Antinociceptive Activity in the Tail-Flick and Formalin Test in Rodents and Reveal Reduced Gastrotoxicity.

Authors:  Marta Szandruk-Bender; Benita Wiatrak; Łukasz Szczukowski; Piotr Świątek; Maria Rutkowska; Stanisław Dzimira; Anna Merwid-Ląd; Maciej Danielewski; Adam Szeląg
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

4.  Synthesis, Characterization and Solubility Determination of 6-Phenyl-pyridazin-3(2H)-one in Different Pharmaceutical Solvents.

Authors:  Faiyaz Shakeel; Mohd Imran; Nazrul Haq; Sultan Alshehri; Md Khalid Anwer
Journal:  Molecules       Date:  2019-09-19       Impact factor: 4.411

5.  Experimental and Computational Approaches for Solubility Measurement of Pyridazinone Derivative in Binary (DMSO + Water) Systems.

Authors:  Faiyaz Shakeel; Sultan Alshehri; Mohd Imran; Nazrul Haq; Abdullah Alanazi; Md Khalid Anwer
Journal:  Molecules       Date:  2019-12-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.